Dividend-News

Daily dividend news for investors in dividend stocks


Healthcare Dogs See Medical Care Tops By Yield But Big Pharma Tops By Gains For April

Published Tue, 18 Apr 2017 19:21:10 -0400 on Seeking Alpha

The Dividend Dogs Rule
Stocks earned the "dog" moniker by exhibiting three traits: (1) paying reliable, repeating dividends, (2) their prices fell to where (3) yield (dividend/price) grew higher than their peers. Thus, the highest yielding stocks in any collection became known as "dogs." More precisely, these are, in fact, best called, "underdogs".
Top 50 April Healthcare Sector Dogs By Yield

Actionable Conclusion (1) Dog Metrics Diagnosed 10 Top Dividend Healthcare Stocks By Yield
Top ten Healthcare Sector dogs selected 4/13/17 by top yield represented six of ten constituent industries. Top yielding healthcare stock, Medical Facilities (OTCPK: MFCSF) [1] was one of three medical care industry representatives.
The two other medical care industry dogs placed second, and tenth, Rhoen Klinikum (OTCPK: RKAGY) [2], and Sonic Healthcare (OTCPK: SKHCF) [10].
The third place Healthcare top ten dog by yield was the first of three drug manufacturers, major firms listed, AstraZeneca (AZN) [3]. The other drug manufacturers, major placed fifth, and ninth: GlaxoSmithKline (GSK) [5], and AbbVie (ABBV) [9].
Fourth place was occupied by the lone diagnostics and research industry representative, National Research (NRCIB) [4].
Two drug manufacturers - specialty & generic placed sixth, and eighth, Indivior (OTCPK: INVVY) [6], and Hypermarcas (OTCPK: HYPMY) [8].
Finally, Extendicare (OTCPK: EXETF) [7], in seventh by yield,... Read more

Stock name Last trade   P/E Earnings/Share Dividend/Share Dividend yield
GLAXOSMITHKLINE 39.05   42.4 0.92 1.92 4.86
NATIONAL RESEARCH 50.10   96.4 0.52 2.40 4.85
ABBVIE 84.76   17.5 4.84 4.28 4.35
BRISTOL-MYERS SQUIBB 49.72   56.5 0.88 1.64 3.42
PFIZER 42.73   10.8 3.95 1.44 3.17
MERIDIAN BIOSCIENCE 16.76   29.9 0.56 0.50 3.04
MERCK & CO 74.50   56.9 1.31 2.20 2.94
SANOFI-AVENTIS 41.67   21.0 1.98 1.20 2.84
ASTRAZENECA 35.55   18.6 1.91 0.88 2.38
NOVARTIS 86.72   15.2 5.70 1.91 2.22

GLAXOSMITHKLINE - GSK
GLAXOSMITHKLINE - GSK  


Older articles featuring Glaxosmithkline (GSK):
5%+ Dividend Yield Portfolio: Beating The Market 2 Of The Last 3 Years (December 2018 Review)
5%+ Dividend Yield Portfolio: Profiting From A Return To Normal (October 2018 Review)
Healthcare Yields Of 3% To 4.8% From Top 10 WallStars In November
Bert's October Dividend Income Summary
5%+ Dividend Yield Portfolio: Playing Offense, Not Running Scared (October 2018 Review)
5%+ Dividend Yield Portfolio: Ignore The Political Circus (Sep 2018 Review)
First Quarterly Update - Steve's Dividend Portfolio And Strategy For Replacing My Salary With Dividend Income
5%+ Dividend Yield Portfolio: Foreign Markets Disappointing You Again? (August 2018 Review)
5%+ Dividend Yield Portfolio: Sticking To The Plan (July 2018 Review)
GlaxoSmithKline: Dividend Safe For Now

More